Several studies describe mutations in TβRI and TβRII in adenomas and gliomas[148,149] as well as correlation between higher expression of TβRI and TβRII with more aggressive glioma cell lines and tumors[150,151]. The gene discussed is TGFBR1; the disease is central nervous system cancer.